Insmed (INSM) Misses Q2 EPS by 2c

November 3, 2016 8:06 AM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Insmed (NASDAQ: INSM) reported Q2 EPS of ($0.61), $0.02 worse than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Insmed (INSM) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment